OFG
GILD icon

OmniStar Financial Group’s Gilead Sciences GILD Stock Holding History

OmniStar Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,697
Closed -$805K – 132
2021
Q2 		$805K Buy
+11,697
New +$781K 1% 37

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

OmniStar Financial Group's GILD Position: Q1 2026 in Review

OmniStar Financial Group reduced its Gilead Sciences (GILD) stake by 28% in Q1 2026, selling an estimated $1.33M and leaving 24,319 shares worth $3.39M. The position accounts for 1.76% of the portfolio, ranked #12.

OmniStar Financial Group first reported a position in GILD in Q4 2017 and has held it in 33 quarters since. The position peaked at $4.16M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • OmniStar Financial Group held 24,319 shares of Gilead Sciences worth $3.39M as of Q1 2026.
  • OmniStar Financial Group sold 9,533 Gilead Sciences shares in Q1 2026, an estimated $1.33M.
  • Gilead Sciences made up 1.76% of OmniStar Financial Group's portfolio in Q1 2026, its #12 holding.
  • OmniStar Financial Group first reported a position in Gilead Sciences in Q4 2017 and has held it in 33 quarters since.
  • OmniStar Financial Group's Gilead Sciences position peaked at $4.16M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on OmniStar Financial Group's 13F filing for Q1 2026, filed 15 May 2026.